Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.1K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Vascular Access Complications in Patients Undergoing Transcatheter Aortic Valve Replacement.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Pharmacological Actions of Potassium Channel Openers on Voltage-Gated Potassium Channels.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

RNA Sequencing Identified Differentially Expressed Genes in the Mesocorticolimbic and Nigrostriatal Systems of Compulsive METH-Taking Rats.

Cells·2025
Same author

PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse.

Current neuropharmacology·2025
Same author

Escalated oxycodone self-administration is associated with expression of voltage gated and calcium activated potassium channels in the mesocorticolimbic system in rats.

Frontiers in pharmacology·2025
Same author

Escalated Oxycodone Self-Administration Is Associated with Activation of Specific Gene Networks in the Rat Dorsal Striatum.

International journal of molecular sciences·2025
Same journal

Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently.

PloS one·2026
Same journal

Top-down and bottom-up attention for joint pattern classification and reconstruction.

PloS one·2026
Same journal

Short- and long-term scaling behavior of blood pressure and pulse arrival time during sleep in healthy controls and patients with obstructive sleep apnea.

PloS one·2026
Same journal

Double DQN-based secrecy energy efficiency and fairness performance in IRS-assisted NOMA systems with friendly jamming.

PloS one·2026
Same journal

10 recommendations for strengthening citizen science for improved societal and ecological outcomes: A co-produced analysis of challenges and opportunities in the 21st century.

PloS one·2026
Same journal

Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.

PloS one·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K

Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

Panayotis K Thanos1, Ronald Kim2, Foteini Delis3

  • 1Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, United States of America.

Plos One
|June 9, 2016
PubMed
Summary
This summary is machine-generated.

Chronic methamphetamine (MA) use causes brain structure changes and altered glucose metabolism in rats. These findings in MA addiction research support clinical observations of neurotoxicity.

More Related Videos

A Hydrophobic Tissue Clearing Method for Rat Brain Tissue
08:24

A Hydrophobic Tissue Clearing Method for Rat Brain Tissue

Published on: December 23, 2020

4.6K
A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

17.9K

Related Experiment Videos

Last Updated: Mar 19, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K
A Hydrophobic Tissue Clearing Method for Rat Brain Tissue
08:24

A Hydrophobic Tissue Clearing Method for Rat Brain Tissue

Published on: December 23, 2020

4.6K
A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

17.9K

Area of Science:

  • Neuroscience
  • Toxicology
  • Addiction Research

Background:

  • Methamphetamine (MA) addiction is a global health crisis.
  • Chronic MA use is linked to neurotoxicity, with human studies showing enlarged striatal volumes and reduced brain glucose metabolism (BGluM).

Purpose of the Study:

  • To investigate the effects of chronic MA treatment on brain structure, microglial activation, and brain function in a rodent model.
  • To correlate neurochemical and metabolic changes with structural alterations.

Main Methods:

  • Rats received daily i.p. injections of saline, low-dose MA (4 mg/kg), or high-dose MA (8 mg/kg) for four months.
  • Brain structure and volume were assessed using 21T MRI.
  • Microglial activation was measured via [3H]PK 11195 autoradiography.
  • Regional BGluM was evaluated using [18F] fluorodeoxyglucose (FDG) micro-PET imaging.

Main Results:

  • High-dose MA treatment led to enlarged striatal volumes and increased microglial activation in the striatum, nucleus accumbens, frontal cortex, rhinal cortices, and cerebellar nuclei.
  • Low-dose MA increased BGluM in specific cortical and thalamic regions, while high-dose MA increased BGluM in somatosensory and retrosplenial cortices.
  • Both doses reduced BGluM in the striatum tail, rhinal cortex, and subiculum, with high-dose MA also decreasing hippocampal BGluM.

Conclusions:

  • Chronic MA exposure induces significant structural and functional brain changes in rats, including neuroinflammation and altered glucose metabolism.
  • These preclinical findings corroborate human clinical observations of MA-induced neurotoxicity.
  • The study provides insights into the mechanisms underlying methamphetamine addiction and its neurological consequences.